Sino Biopharmaceutical is a pharmaceutical company that develops, makes and markets medicines, chiefly for patients in mainland China. Its products span several therapeutic areas, including treatments for hepatitis B and other liver diseases, oncology medicines, and a range of injectable and oral drugs used in hospitals. The company is based in Hong Kong and works through operating subsidiaries in China, supplying prescription medicines to hospitals and healthcare providers.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 1177, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #639 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendFair
65/100
Mixed trend against its averages.
See the numbers →
Above 200-day average-2.1%
From 52-week high-29.1%
MomentumFair
57/100
Typical recent returns for this exchange.
See the numbers →
3-month return7.0%
6-month return-7.8%
12-month, skipping last month-28.7%
Stability (higher is calmer)Fair
64/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)41.0%
Worst drawdown, 1 year (smaller is calmer)-44.8%
LiquidityStrong
97/100
Trades actively.
See the numbers →
Avg daily value traded413.87M HKD
Zero-volume days0.0%
IncomeWeak
39/100
Dividend is small or irregular.
See the numbers →
Dividend yield2.2%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 4.136 – 7.886Daily closes, split-adjusted
Signals
50-day average5.397
200-day average5.518
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.238
Technical summary
Daily
Neutral
5 bullish · 4 neutral · 7 bearish
Weekly
Bullish
7 bullish · 1 neutral · 4 bearish
Monthly
Neutral
3 bullish · 1 neutral · 4 bearish
Moving averages (daily)
SMA 10
5.42
Bearish
EMA 10
5.39
Bullish
SMA 20
5.53
Bearish
EMA 20
5.44
Bearish
SMA 50
5.40
Bullish
EMA 50
5.39
Bullish
SMA 100
5.08
Bullish
EMA 100
5.35
Bullish
SMA 200
5.52
Bearish
EMA 200
5.45
Bearish
Oscillators (daily)
RSI (14)
48.47
Neutral
MACD (12, 26)
-0.04
Bearish
Momentum (12)
-5.43
Bearish
Stochastic %K (14)
38.41
Neutral
Williams %R (14)
-61.59
Neutral
CCI (20)
-84.07
Neutral
Pivot points (classic, last session)
S3
5.02
S2
5.11
S1
5.26
Pivot
5.35
R1
5.49
R2
5.58
R3
5.73
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.12 HKD
Yield on today's price
2.22%
Frequency
Semi-annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
1 Sep 2026
0.0700
24 Jun 2026
0.0500
29 Aug 2025
0.0500
16 Jun 2025
0.0400
10 Sep 2024
0.0300
11 Jun 2024
0.0300
4 Oct 2023
0.0200
20 Jun 2023
0.0600
6 Sep 2022
0.0600
15 Jun 2022
0.0400
13 Sep 2021
0.0200
18 Jun 2021
0.0200
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
